Plasmid Gene Therapy for Monogenic Disorders: Challenges and Perspectives
Monogenic disorders are a group of human diseases caused by mutations in single genes. While some disease-altering treatments offer relief and slow the progression of certain conditions, the majority of monogenic disorders still lack effective therapies. In recent years, gene therapy has appeared as...
Saved in:
Main Authors: | Marco A. Luís, Marcelo A. D. Goes, Fátima Milhano Santos, Joana Mesquita, Paulo Tavares-Ratado, Cândida Teixeira Tomaz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/17/1/104 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical and molecular characterisation of children with monogenic obesity:
a case series
by: Arun George, et al.
Published: (2024-07-01) -
Advances in Gene Therapy for Neurologic Disorders: An Overview
by: Pallavi Chand, et al.
Published: (2025-02-01) -
Polymorphism of monogenic scab resistance loci in apple varieties
by: A. S. Lyzhin, et al.
Published: (2020-04-01) -
Current views on etiology, diagnosis, epidemiology and gene therapy of maturity onset diabetes in the young
by: Lilya U. Dzhemileva, et al.
Published: (2025-01-01) -
Non-Viral Delivery Systems to Transport Nucleic Acids for Inherited Retinal Disorders
by: Md Jobair Jony, et al.
Published: (2025-01-01)